WVPAC 2019 venue for BI’s presentation of hatchery vaccination solutions

Boehringer Ingelheim will be on concourse Bhiraj hall, 2nd floor, booth D4 of the 21st World Veterinary Poultry Association Congress to present its solutions for hatchery vaccination. Those solutions include NEWXXITEK® HVT+ND, the HVT vector vaccine that protects against Newcastle disease without inducing any post-vaccination adverse reaction; VAXXITEK® HVT+IBD, the HVT vector vaccine that protects against infectious bursal disease; the new leader in IBD vector vaccine technology VAXXITEK® HVT+IBD+ND, which received USDA approval last month. There are also Mass and Variant IB vaccines for a cross-serotype protection, like Hatchpak® Bioral H120 which facilitates a high number of doses per amp hatchery vaccination solution, and Bioral H120 NeO and Gallivac IB88 NeO which are available as effervescent tablets for easier vaccination administration. BI’s In-Ovo machine Ovo-Jector, which can selectively vaccinate up to 42,000 eggs per hour, and BI’s Vaccination Technologies and Services will also be showcased.
Jérôme Baudon, BI’s Head of Poultry Business Unit, said: “This year’s theme of the conference is ‘Poultry: the value of protein for one’s health’ focusing on food safety and biosecurity. Both fit very well with our aspiration to create the future of poultry well-being through preventive care. We look forward to engaging with experts and opinion leaders in productive conversations at the event.”
BI’s VTS Global Head, Chris Fritts, said: “The Vaccination Technologies and Services has been identified as a strategic initiative for our poultry business and it is fully in line with our goal to provide best services to hatcheries. Vaccination equipment is an integral part of our value proposition.”